Cargando…

Long-term disability progression of pediatric-onset multiple sclerosis

OBJECTIVE: To evaluate long-term disability progression in pediatric-onset multiple sclerosis (POMS) and compare to adult-onset multiple sclerosis (AOMS). METHODS: This was a retrospective cohort study using prospectively collected clinical information from the Swedish MS Registry. Clinical features...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKay, Kyla A., Hillert, Jan, Manouchehrinia, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598792/ https://www.ncbi.nlm.nih.gov/pubmed/31092624 http://dx.doi.org/10.1212/WNL.0000000000007647

Ejemplares similares

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
por: McKay, Kyla A., et al.
Publicado: (2020)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
por: Song, Jie, et al.
Publicado: (2018)

Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
por: Karrenbauer, Virginija Danylaité, et al.
Publicado: (2021)

Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
por: McKay, Kyla A., et al.
Publicado: (2021)

Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
por: He, Anna, et al.
Publicado: (2023)

Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
por: McKay, Kyla A., et al.
Publicado: (2022)

A multiple sclerosis disease progression measure based on cumulative disability
por: Manouchehrinia, Ali, et al.
Publicado: (2021)

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
por: He, Anna, et al.
Publicado: (2023)

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
por: He, Anna H, et al.
Publicado: (2023)

Association between brain volume and disability over time in multiple sclerosis
por: Moridi, Thomas, et al.
Publicado: (2022)

Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review
por: McKay, Kyla A., et al.
Publicado: (2015)

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study
por: Boles, Graysen Steele, et al.
Publicado: (2023)

Depression and multiple sclerosis: A bidirectional Mendelian randomisation study
por: Binzer, Stefanie, et al.
Publicado: (2021)

Age Related Multiple Sclerosis Severity Score: Disability ranked by age
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2013)

The long-term impact of early treatment of multiple sclerosis on the risk of disability pension
por: Landfeldt, Erik, et al.
Publicado: (2018)

Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis
por: Hedström, Anna Karin, et al.
Publicado: (2021)

Importance of early treatment decisions on future income of multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2020)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Accurate classification of secondary progression in multiple sclerosis using a decision tree
por: Ramanujam, Ryan, et al.
Publicado: (2020)

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
por: McKay, Kyla A., et al.
Publicado: (2021)

Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
por: Manouchehrinia, Ali, et al.
Publicado: (2018)

Income in Multiple Sclerosis Patients with Different Disease Phenotypes
por: Kavaliunas, Andrius, et al.
Publicado: (2017)

Administrative data for observational research in multiple sclerosis: Opportunities and challenges
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2020)

Season of birth is associated with multiple sclerosis and disease severity
por: Stridh, P, et al.
Publicado: (2021)

Self‐employment, sickness absence, and disability pension in multiple sclerosis
por: Machado, Alejandra, et al.
Publicado: (2022)

Long‐term evolution of multiple sclerosis disability in the treatment era
por: Cree, Bruce A. C., et al.
Publicado: (2016)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Long-Term Consequences of High Titer Neutralizing Antibodies to Interferon-β in Multiple Sclerosis
por: Dunn, Nicky, et al.
Publicado: (2020)

Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma
por: Montgomery, Scott, et al.
Publicado: (2016)

Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden
por: Karampampa, Korinna, et al.
Publicado: (2022)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019)

Cognitive function predicts work disability among multiple sclerosis patients
por: Kavaliunas, Andrius, et al.
Publicado: (2019)

Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis
por: Raffel, Joel, et al.
Publicado: (2017)

Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability
por: Giorgio, Antonio, et al.
Publicado: (2017)

Current Advances in Pediatric Onset Multiple Sclerosis
por: Fisher, Kristen S., et al.
Publicado: (2020)

Systematic Review of the Socioeconomic Consequences in Patients With Multiple Sclerosis With Different Levels of Disability and Cognitive Function
por: Kavaliunas, Andrius, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q1jin9b8e3koi42tir0i4vaav2